Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more


The latest news for pharma industry insiders.

Rare Disease Summit Recap

Greater Than One’s Chief Strategy Officer, Andrew Bast, came away from the 2024 Rare Disease Summit in Philadelphia, PA, held this year on March 18th-21st, feeling empowered and inspired. Miranda Schmalfuhs recently connected with him for a Q&A on his experience and what takeaways he found most fascinating and profound.

Diabetes Weight Loss Drugs Could be Linked to Reduced Risk of MS, Study Finds

Drug repurposing has recently emerged as an attractive pathway for developing new treatments due to its relatively fast and cost-efficient trajectory. Because obesity and MS share inflammatory properties, researchers used data from the FDA Adverse Event Reporting System to investigate the association between weight loss-inducing drugs and MS

Artificial Intelligence’s ‘Insatiable’ Energy Needs Not Sustainable, Arm CEO Says

AI models such as OpenAI’s ChatGPT ‘are just insatiable in terms of their thirst’ for electricity, Haas said

Walmart Health Expands in Texas with 18 New Locations

Residents in Texas can experience affordable and integrated healthcare services all in one convenient location with the opening of three new Walmart Health centers in Pearland (10505 Broadway St, Pearland, TX), Sugar Land (345 Highway 6, Sugar Land, TX) and Tomball (22605 Tomball Pkwy, Tomball, TX). These locations are the first of 18 new Walmart Health centers coming to Texas this year, complementing the existing four sites in the state.

Cencora | Pharma solution on LinkedIn:

The Inflation Reduction Act has brought with it greater pricing pressures.

In a recent interview with Pharmaceutical Commerce Magazine, VP of Reimbursement & Policy Insights Corey Ford shares how we help clients to best address and adapt to this law. We want clients to understand how to change eligibility criteria, engage payers, and leverage medical communications.

Read the full article ➡️

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.